Log-in / Create Account  
Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Handling Investigational Drugs 101: Tips of the Trade from Experienced Investigational Drug Service Practitioners
Track: Educational Sessions
Program Code: 248-L03
Date: Tuesday, December 9, 2008
Time: 3:00 PM to 4:30 PM EST
Location: W309A
MEETING PLANNING ASSOCIATE:   Click the plus sign to see more detailed information about each speaker.
 Manisha Hong, BS, Investigational Drug Pharmacist, The Johns Hopkins Hospital
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Christine Formea, PharmD, Research Manager, Pharmacy Services, Mayo Clinic, St. Mary's Hospital
 Manisha Hong, BS, Investigational Drug Pharmacist, The Johns Hopkins Hospital
Hye Kim, BS Pharmacy, BS chemistry, investigational drug pharmacist, the Johns Hopkins Hospital
 Darlette Luke, RPh, Investigational drug pharmacst, University of Minnesota Medical Center, Fairview

  • Delineate investigational drug issues relevant to Joint Commission inspections.
  • Describe the relationship between the Investigational Drug Service and the Institutional Review Board.
  • Discuss health-system pharmacy policies and procedures needed to meet regulatory and research standards specific to investigational drugs.
  • Explain the pharmacist's role in drug accountability and record keeping for studies where the drug is held by the investigator.

Audio Synchronized to PowerPoint
View
Handout Online
View